tiprankstipranks
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market

Halozyme (HALO) Income Statement

Compare
972 Followers

Halozyme Income Statement

Last quarter (Q4 2024), Halozyme's total revenue was $298.01M, an increase of 29.55% from the same quarter last year. In Q4, Halozyme's net income was $137.01M. See Halozyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.02B$ 829.25M$ 660.12M$ 443.31M$ 267.59M
Gross Profit
$ 855.91M$ 636.89M$ 520.81M$ 361.90M$ 224.23M
Operating Expenses
$ 304.43M$ 299.32M$ 253.28M$ 86.00M$ 79.97M
Depreciation and Amortization
$ 81.31M$ 84.86M$ 49.64M$ 3.00M$ 3.28M
EBITDA
$ 656.54M$ 451.95M$ 315.51M$ 259.04M$ 152.96M
Operating Income
$ 551.48M$ 337.57M$ 267.53M$ 275.90M$ 144.25M
Other Income/Expenses
$ 5.66M$ 10.76M$ -18.61M$ -27.38M$ -14.95M
Pretax Income
$ 557.13M$ 348.33M$ 248.92M$ 248.52M$ 129.30M
Net Income
$ 444.09M$ 281.59M$ 202.13M$ 402.71M$ 129.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.50$ 2.13$ 1.48$ 2.86$ 0.95
Diluted EPS
$ 3.43$ 2.10$ 1.44$ 2.74$ 0.91
Weighted Average Shares Outstanding
126.83M 131.93M 136.84M 140.65M 136.21M
Weighted Average Shares Outstanding (Diluted)
129.42M 134.20M 140.61M 146.80M 141.46M
Currency in USD

Halozyme Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis